BIOMAT Database Logo BIOMAT Database Logo

The detection of endotoxin in parenteral products by LAL test. 1997

J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Department of Sera and Vaccines Research National Institute of Hygiene, Warsaw, Poland.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008033 Limulus Test Sensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate (LAL), prepared from the circulating blood (amebocytes) of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals. Limulus Tests,Test, Limulus,Tests, Limulus
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D000418 Albumins Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating. Albumin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014121 Toxoids Preparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis. They include deactivated toxins. Anatoxin toxoids are distinct from anatoxins that are TROPANES found in CYANOBACTERIA. Anatoxin Toxoid,Toxins, Deactivated,Toxoid,Anatoxin Toxoids,Deactivated Toxins,Toxoid, Anatoxin,Toxoids, Anatoxin
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I

Related Publications

J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Application of the LAL test and the chromogenic substrate test to the detection of endotoxin in human blood products.
January 1982, Progress in clinical and biological research,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
The effect of refrigeration and mixing on detection of endotoxin in parenteral drugs using the Limulus Amebocyte Lysate (LAL) test.
January 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Detection of endotoxin in biological products by the limulus test.
January 1977, Developments in biological standardization,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Applications and advantages of the Limulus amebocyte lysate (LAL) pyrogen test for parenteral injectable products.
January 1979, Progress in clinical and biological research,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Quantitation of endotoxin in products using the LAL kinetic turbidimetric assay.
January 1987, Progress in clinical and biological research,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Guideline for validation of the LAL test as an end-product endotoxin test for human and biological drug products.
January 1985, Progress in clinical and biological research,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
The Limulus Amoebocyte Lysate (LAL) assay for the detection of endotoxin in fat emulsions for total parenteral nutrition (TPN).
June 1984, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
The limulus amebocyte lysate (LAL) test for endotoxin in human plasma.
August 1979, Thrombosis and haemostasis,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
[Blood endotoxin in acute pancreatitis using limulus amebocyte lysate test (LAL test)].
March 1990, Minerva chirurgica,
J Aleksandrowicz, and M Fiejka, and Z Kudelski, and A Marciniak-Rusek, and L Paśś-Dziegielewska
Application of LAL for detection of endotoxin in antibiotic preparations.
January 1979, Progress in clinical and biological research,
Copied contents to your clipboard!